Suven Pharmaceuticals Limited (SUVENPHAR) — Working Capital to Net Assets Ratio
Suven Pharmaceuticals Limited (SUVENPHAR) has a Working Capital to Net Assets ratio of 28.4% as of March 2025. Working capital of Rs5.23 Billion (current assets of Rs8.89 Billion minus current liabilities of Rs3.65 Billion) is measured against net assets of Rs18.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See SUVENPHAR net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Suven Pharmaceuticals Limited Working Capital to Net Assets (2019–2025)
This chart shows how Suven Pharmaceuticals Limited's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2025, the ratio stands at 28.4%, reflecting working capital of Rs5.23 Billion against net assets of Rs18.41 Billion INR. Check SUVENPHAR tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Suven Pharmaceuticals Limited (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Suven Pharmaceuticals Limited from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Suven Pharmaceuticals Limited.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 28.4% | Rs5.23 Billion | Rs18.41 Billion | Rs8.89 Billion | Rs3.65 Billion | ▼ -28.0 pp |
| 2024 | 56.4% | Rs11.56 Billion | Rs20.51 Billion | Rs12.63 Billion | Rs1.07 Billion | ▲ +7.3 pp |
| 2023 | 49.1% | Rs8.52 Billion | Rs17.35 Billion | Rs10.11 Billion | Rs1.59 Billion | ▼ -11.0 pp |
| 2022 | 60.1% | Rs9.18 Billion | Rs15.27 Billion | Rs11.28 Billion | Rs2.10 Billion | ▲ +30.9 pp |
| 2021 | 29.2% | Rs3.45 Billion | Rs11.81 Billion | Rs5.65 Billion | Rs2.20 Billion | ▲ +6.6 pp |
| 2020 | 22.6% | Rs1.91 Billion | Rs8.45 Billion | Rs3.92 Billion | Rs2.00 Billion | ▼ -16.7 pp |
| 2019 | 39.3% | Rs2.32 Billion | Rs5.90 Billion | Rs3.90 Billion | Rs1.58 Billion | — |